Analyst Price Targets — SDGR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 7, 2026 6:02 am | Michael Yee | UBS | $18.00 | $18.79 | StreetInsider | UBS Starts Schrodinger (SDGR) at Neutral |
| September 29, 2025 8:38 pm | — | Goldman Sachs | $19.00 | $20.04 | TheFly | Schrodinger initiated with a Neutral at Goldman Sachs |
| November 13, 2024 12:41 pm | Gary Nachman | BMO Capital | $28.00 | $18.91 | StreetInsider | Schrodinger (SDGR) PT Raised to $28 at BMO Capital |
| September 23, 2024 9:42 am | Chris Shibutani | Goldman Sachs | $27.00 | $19.60 | StreetInsider | Goldman Sachs Reiterates Neutral Rating on Schrodinger (SDGR) |
| August 21, 2024 6:47 am | Vikram Purohit | Morgan Stanley | $30.00 | $20.44 | StreetInsider | Schrodinger (SDGR) PT Lowered to $30 at Morgan Stanley |
| July 2, 2024 7:38 am | Mani Foroohar | Leerink Partners | $29.00 | $18.76 | TheFly | Schrodinger initiated with an Outperform at Leerink |
| December 19, 2022 4:39 am | Chris Shibutani | Goldman Sachs | $23.00 | $20.54 | TheFly | Schrodinger initiated with a Neutral at Goldman Sachs |
Latest News for SDGR
The Pentagon just earmarked over $74 billion for drone dominance and counter drone technologies in the FY2027 budget request, and that is only one slice of the AI arms race AMD and NVIDIA are fighting over.
On June 30, 2026, Schrodinger Inc (SDGR) shares fell 6.6% today, bringing the current price to $16.25. Over the past 52 weeks, shares have traded as high as $23
Artificial intelligence is reshaping nearly every industry, but some of its biggest opportunities are emerging far from Silicon Valley. Biotechnology has spent decades producing breakthrough medicines, yet drug development has remained painfully slow, often taking 10 to 15 years while roughly 90% of candidates never reach approval. AI is beginning to change that equation. By... AI Is Transforming Drug Discovery.…
Schrödinger, Inc. (Nasdaq: SDGR) today reported that on June 12, 2026, the company granted restricted stock units (RSUs) with respect to 10,771 shares of the
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on June 12, 2026, the company granted restricted stock units (RSUs) with respect to 10,771 shares of the company's common stock to seven newly hired employees. These grants were made pursuant to the company's 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SDGR.
U.S. House Trading
No House trades found for SDGR.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.